
Surgical Oncology for the General Surgeon
The purpose of Surgical Oncology for the General Surgeon is to update the community surgeon with the latest advances in cancer care, including, but not limited to, how tumor biology influences the surgical care of cancer patients, the proper sequencing of therapies and advances in therapies, use of genetic and genomic testing, and the findings of the latest cancer clinical trials.
Target Audience
- Breast surgeons
- Colorectal surgeons
- General surgeons
- Nurses
- Physicians in accredited cancer centers and programs
- Surgical oncologists
Learning Objectives
- Review the indications and application of (neo)adjuvant therapy and molecular profiling for solid tumors of the breast, skin, and colon.
- Understand the technical tips and operative standards for solid tumors of the breast, skin, and colon.
- Discuss recent clinical trial findings and outline the application of results to patient management.
Contact
- For questions about the course, please contact cancerresearchprogram@facs.org.
- If you have any technical questions, contact learning@facs.org.
Disclosure Information
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.
Ineligible company
The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Financial Relationships
Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Speakers/Moderators/Discussants/Authors
Flavio Rocha, MD, FACS, FSSO (moderator)—Nothing to disclose
Oregon Health & Science University/Knight Cancer Institute
Genevieve Boland, MD, PhD, FACS (speaker)—Scientific Advisory Board/Steering Committee at Nektar Therapeutics, Honorarium from Novartis, Sponsored Research Agreement from Palleon Pharmaceuticals, Sponsored Research Agreement from Olink Proteomics
Massachusetts General Hospital
Sepideh Gholami, MD, FACS (speaker)—Nothing to disclose
UC Davis Health
Arpana Naik, MD, FACS (speaker)—Nothing to disclose
Oregon Health & Science University
Planning Committee/Editorial Committee
Judy Boughey, MD, FACS—Research funding support for clinical trial from Eli Lilly
Mayo Clinic
Christina Roland, MD, FACS—Research funds to institution from Bristol Myers Squibb
MD Anderson Cancer Center
Asa Carter, MBA, CTR—Nothing to disclose
American College of Surgeons
Amanda Francescatti, MS—Nothing to disclose
American College of Surgeons
Linda Zheng—Nothing to disclose
American College of Surgeons
Continuing Medical Education Credit Information
Accreditation
The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™
The American College of Surgeons designates this internet enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 CE Contact hours
- 1.00 Certificate of Completion